| Patent | Date |
|---|
Crystalline Solid Forms Of A Bet Inhibitor
App 20220306628 - Chen; Shili ; et al. | 2022-09-29 |
Imidazole And Triazole Kras Inhibitors
App 20220306633 - Qi; Chao ; et al. | 2022-09-29 |
Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,- 4]triazin-2-yl]benzamide and processes related to preparing the same
Grant 11,452,726 - Weng , et al. September 27, 2 | 2022-09-27 |
Tricyclic amine compounds as CDK2 inhibitors
Grant 11,447,494 - Ye , et al. September 20, 2 | 2022-09-20 |
Salts of the Janus Kinase Inhibitor (R)-3-(4-(7h-Pyrrolo[2,3-D]Pyrimidin-4-YL)-1h-Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile
App 20220288078 - Li; Hui-Yin ; et al. | 2022-09-15 |
Tricyclic amine compounds as CDK2 inhibitors
Grant 11,440,914 - Ye , et al. September 13, 2 | 2022-09-13 |
Ruxolitinib Formulation For Reduction Of Itch In Atopic Dermatitis
App 20220280518 - Kuligowski; Michael ; et al. | 2022-09-08 |
Spirocyclic Lactams As Jak2 V617f Inhibitors
App 20220281887 - Shepard; Stacey ; et al. | 2022-09-08 |
Heterocyclylamines as PI3K inhibitors
Grant 11,433,071 - Li , et al. September 6, 2 | 2022-09-06 |
Formulations Of An Axl/mer Inhibitor
App 20220273663 - Rocco; William L. ; et al. | 2022-09-01 |
Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
Grant 11,427,567 - Ye , et al. August 30, 2 | 2022-08-30 |
Heteroaryl amide compounds as sting activators
Grant 11,427,597 - Wu , et al. August 30, 2 | 2022-08-30 |
Imidazopyridazine and imidazopyridine compounds and uses thereof
Grant 11,427,592 - Pan , et al. August 30, 2 | 2022-08-30 |
Heterocyclic compounds as immunomodulators
Grant 11,414,433 - Wu , et al. August 16, 2 | 2022-08-16 |
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS
App 20220251087 - Buesking; Andrew W. ; et al. | 2022-08-11 |
JAK1 pathway inhibitors for the treatment of chronic lung allograft dysfunction
Grant 11,406,640 - Schaub , et al. August 9, 2 | 2022-08-09 |
Derivatives of an FGFR inhibitor
Grant 11,407,750 - Tao , et al. August 9, 2 | 2022-08-09 |
Pyrazolopyridine compounds and uses thereof
Grant 11,406,624 - Sokolsky , et al. August 9, 2 | 2022-08-09 |
Heterocyclic compounds as immunomodulators
Grant 11,407,749 - Wu , et al. August 9, 2 | 2022-08-09 |
Combination Therapy With An Anti-cd19 Antibody And Parsaclisib
App 20220241411 - Langmuir; Peter | 2022-08-04 |
Treatment Of Hidradenitis Suppurativa Using Jak Inhibitors
App 20220241286 - Howell; Michael D. ; et al. | 2022-08-04 |
Pyrido[3,2-d]pyrimidine compounds as immunomodulators
Grant 11,401,279 - Li , et al. August 2, 2 | 2022-08-02 |
Pyrimidinones as PI3K inhibitors
Grant 11,401,280 - Li , et al. August 2, 2 | 2022-08-02 |
Heterocyclic compounds as LSD1 inhibitors
Grant 11,401,272 - He , et al. August 2, 2 | 2022-08-02 |
Combination Therapy Comprising A2a/a2b Inhibitors, Pd-1/pd-l1 Inhibitors, And Anti-cd73 Antibodies
App 20220233529 - Wang; Hui ; et al. | 2022-07-28 |
Substituted heterocyclic derivatives as PI3K inhibitors
Grant 11,396,502 - Shepard , et al. July 26, 2 | 2022-07-26 |
Pyrazolopyridine Compounds And Uses Thereof
App 20220227752 - Liu; Kai ; et al. | 2022-07-21 |
Combination Therapy Comprising Jak Pathway Inhibitor And Rock Inhibitor
App 20220226327 - Peel; Michael ; et al. | 2022-07-21 |
Salts Of Tam Inhibitors
App 20220227770 - Jia; Zhongjiang ; et al. | 2022-07-21 |
Pyridine And Pyridimine Compounds As Pi3k-gamma Inhibitors
App 20220227736 - Sparks; Richard B. ; et al. | 2022-07-21 |
Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
Grant 11,390,624 - Huang , et al. July 19, 2 | 2022-07-19 |
Substituted spiro[cyclopropane-1,5'-pyrrolo[2,3-d]pyrimidin]-6'(7'h)-ones as CDK2 inhibitors
Grant 11,384,083 - Sokolsky , et al. July 12, 2 | 2022-07-12 |
Pyrrole Tricyclic Compounds As A2a / A2b Inhibitors
App 20220213112 - Wang; Xiaozhao ; et al. | 2022-07-07 |
Topical Formulation For A Jak Inhibitor
App 20220211707 - Parikh; Bhavnish ; et al. | 2022-07-07 |
Sustained-release Dosage Forms Of Ruxolitinib
App 20220211631 - Ni; Yong ; et al. | 2022-07-07 |
TERTIARY ALCOHOLS AS PI3K-y INHIBITORS
App 20220213107 - Douty; Brent ; et al. | 2022-07-07 |
Deazaguaine Compounds As Jak2 V617f Inhibitors
App 20220213108 - Buesking; Andrew W. ; et al. | 2022-07-07 |
Heterocyclic Compounds As Immunomodulators
App 20220213090 - Wu; Liangxing ; et al. | 2022-07-07 |
Topical Formulation For A Jak Inhibitor
App 20220211712 - Parikh; Bhavnish ; et al. | 2022-07-07 |
AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
App 20220213065 - Shepard; Stacey ; et al. | 2022-07-07 |
Crystalline solid forms of a BET inhibitor
Grant 11,377,446 - Chen , et al. July 5, 2 | 2022-07-05 |
Jak Inhibitor With A Vitamin D Analog For Treatment Of Skin Diseases
App 20220202834 - SMITH; Paul ; et al. | 2022-06-30 |
Biomarkers for graft-versus-host disease
Grant 11,372,003 - Howell , et al. June 28, 2 | 2022-06-28 |
Heterocyclic Compounds As Immunomodulators
App 20220194931 - Wu; Liangxing ; et al. | 2022-06-23 |
Oral Formulation For A Pd-l1 Inhibitor
App 20220193050 - Yang; Yonglai ; et al. | 2022-06-23 |
Anti-cd19 Combination Therapy
App 20220184208 - FINGERLE-ROWSON; Gunter ; et al. | 2022-06-16 |
Jak1 Pathway Inhibitors For The Treatment Of Vitiligo
App 20220175731 - Smith; Paul ; et al. | 2022-06-09 |
Bicyclic Heteroarylaminoalkyl Phenyl Derivatives As Pi3k Inhibitors
App 20220177491 - Li; Yun-Long ; et al. | 2022-06-09 |
Pyridine and pyridimine compounds as PI3K-gamma inhibitors
Grant 11,352,340 - Sparks , et al. June 7, 2 | 2022-06-07 |
Tricyclic Urea Compounds As Jak2 V617f Inhibitors
App 20220169649 - Ai; Yanran ; et al. | 2022-06-02 |
Solid Forms Of An Hpk1 Inhibitor
App 20220162195 - Jia; Zhongjiang ; et al. | 2022-05-26 |
Heterocyclic compounds as immunomodulators
Grant 11,339,149 - Wu , et al. May 24, 2 | 2022-05-24 |
Sustained-release dosage forms of ruxolitinib
Grant 11,337,927 - Ni , et al. May 24, 2 | 2022-05-24 |
Salts Of An Fgfr Inhibitor
App 20220153740 - Jia; Zhongjiang ; et al. | 2022-05-19 |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
Grant 11,331,320 - Rodgers , et al. May 17, 2 | 2022-05-17 |
Process Of Preparing A Pd-1/pd-l1 Inhibitor
App 20220144830 - Zhou; Jiacheng ; et al. | 2022-05-12 |
Crystalline Form Of A Pd-1/pd-l1 Inhibitor
App 20220144832 - Jia; Zhongjiang ; et al. | 2022-05-12 |
Process For Making A Pd-1/pd-l1 Inhibitor And Salts And Crystalline Forms Thereof
App 20220144831 - Wang; Dengjin ; et al. | 2022-05-12 |
Combination therapy for treatment of hematological diseases
Grant 11,324,749 - Assad May 10, 2 | 2022-05-10 |
Fused Pyrazine Derivatives As A2a / A2b Inhibitors
App 20220135570 - Wang; Xiaozhao ; et al. | 2022-05-05 |
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders
App 20220119393 - Li; Yun-Long ; et al. | 2022-04-21 |
Treatment of hidradenitis suppurativa using JAK inhibitors
Grant 11,304,949 - Howell , et al. April 19, 2 | 2022-04-19 |
3-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related compounds as PI3K-gamma kinase inhibitors
Grant 11,306,079 - Shvartsbart , et al. April 19, 2 | 2022-04-19 |
Crystalline Forms Of A Phosphoinositide 3-kinase (pi3k) Inhibitor
App 20220112198 - Douty; Brent ; et al. | 2022-04-14 |
Benzimidazole and indole compounds and uses thereof
Grant 11,299,473 - Hummel , et al. April 12, 2 | 2022-04-12 |
Bicyclic Dione Compounds As Inhibitors Of Kras
App 20220106309 - Huang; Taisheng ; et al. | 2022-04-07 |
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders
App 20220106318 - Li; Yun-Long ; et al. | 2022-04-07 |
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant 11,285,140 - Huang , et al. March 29, 2 | 2022-03-29 |
Heterocyclic Compounds As Immunomodulators
App 20220089588 - Wu; Liangxing ; et al. | 2022-03-24 |
Low dose combination therapy for treatment of myeloproliferative neoplasms
Grant 11,278,541 - Koblish , et al. March 22, 2 | 2022-03-22 |
Tricyclic Heterocyclic Compounds As Sting Activators
App 20220073509 - Wu; Liangxing ; et al. | 2022-03-10 |
Vinyl Imidazole Compounds As Inhibitors Of Kras
App 20220064188 - Carlsen; Peter ; et al. | 2022-03-03 |
Tricyclic Urea Compounds As Jak2 V617f Inhibitors
App 20220064165 - Liu; Kai ; et al. | 2022-03-03 |
Imidazotriaines and imidazopyrimidines as kinase inhibitors
Grant 11,261,191 - Zhuo , et al. March 1, 2 | 2022-03-01 |
Process And Intermediates For Preparing A Jak1 Inhibitor
App 20220056034 - Zhou; Jiacheng ; et al. | 2022-02-24 |
Heteroaryl Amide Compounds As Sting Activators
App 20220056049 - Wu; Liangxing ; et al. | 2022-02-24 |
Process And Intermediates For Preparing A Jak Inhibitor
App 20220056035 - Zhou; Jiacheng ; et al. | 2022-02-24 |
Cyclopropylamines as LSD1 inhibitors
Grant 11,247,992 - Wu , et al. February 15, 2 | 2022-02-15 |
Processes For The Preparation Of Arginase Inhibitors And Their Synthetic Intermediates
App 20220041630 - SCLAFANI; Joseph ; et al. | 2022-02-10 |
Jak1 Pathway Inhibitors For The Treatment Of Cytokine-related Disorders
App 20220040187 - Montgomery; Michael O'Neill ; et al. | 2022-02-10 |
Systems, Methods, And Computer Programs, For Analyzing Images Of A Portion Of A Person To Detect A Severity Of A Medical Condition
App 20220044405 - Jenkins; Julian ; et al. | 2022-02-10 |
Pyrazolopyridine compounds and uses thereof
Grant 11,242,343 - Liu , et al. February 8, 2 | 2022-02-08 |
Formulations of an AXL/MER inhibitor
Grant 11,241,438 - Rocco , et al. February 8, 2 | 2022-02-08 |
Salts And Processes Of Preparing A Pi3k Inhibitor
App 20220024934 - Qiao; Lei ; et al. | 2022-01-27 |
Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors
Grant 11,229,631 - Xue , et al. January 25, 2 | 2022-01-25 |
Pyrazolopyrimidine Compounds And Uses Thereof
App 20220017521 - Vechorkin; Oleg ; et al. | 2022-01-20 |
Sustained Release Dosage Forms For A Jak1 Inhibitor
App 20220016036 - Yeleswaram; Krishnaswamy ; et al. | 2022-01-20 |
Tertiary alcohols as PI3K-.gamma. inhibitors
Grant 11,225,486 - Douty , et al. January 18, 2 | 2022-01-18 |
Bicyclic Heterocycles As Fgfr4 Inhibitors
App 20220009921 - Lu; Liang ; et al. | 2022-01-13 |
Dihydropyrido[2,3-d]pyrimidinone Compounds As Cdk2 Inhibitors
App 20220009923 - Sokolsky; Alexander ; et al. | 2022-01-13 |
Topical formulation for a JAK inhibitor
Grant 11,219,624 - Parikh , et al. January 11, 2 | 2022-01-11 |
Pyrrole tricyclic compounds as A2A / A2B inhibitors
Grant 11,220,510 - Wang , et al. January 11, 2 | 2022-01-11 |
Tricyclic Pyridone Compounds As Jak2 V617f Inhibitors
App 20220002299 - Liu; Kai ; et al. | 2022-01-06 |
Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentyl- propanenitrile
Grant 11,213,528 - Li , et al. January 4, 2 | 2022-01-04 |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
Grant 11,214,573 - Yao , et al. January 4, 2 | 2022-01-04 |
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant 11,207,302 - Combs , et al. December 28, 2 | 2021-12-28 |
Bicyclic Heterocycles As Fgfr Inhibitors
App 20210395246 - Sun; Yaping ; et al. | 2021-12-23 |
Pyrrolotriazine Compounds As Jak2 V617f Inhibitors
App 20210395257 - Yu; Zhiyong ; et al. | 2021-12-23 |
Naphthyridinone Compounds As Jak2 V617f Inhibitors
App 20210395251 - Shepard; Stacey ; et al. | 2021-12-23 |
Heterocyclic Derivatives As Pi3k Inhibitors
App 20210395258 - Shepard; Stacey ; et al. | 2021-12-23 |
Alk2 Inhibitors For The Treatment Of Anemia
App 20210393605 - Seguy; Francis ; et al. | 2021-12-23 |
Imidazopyridazine Compounds And Uses Thereof
App 20210388003 - Pan; Jun ; et al. | 2021-12-16 |
Tricyclic Fused Thiophene Derivatives As Jak Inhibitors
App 20210387998 - Li; Yun-Long ; et al. | 2021-12-16 |
Heterocyclic Compounds As Immunomodulators
App 20210380584 - Wu; Liangxing ; et al. | 2021-12-09 |
Combination Therapy For Treatment Of Myeloproliferative Neoplasms
App 20210379074 - Stubbs; Matthew ; et al. | 2021-12-09 |
Processes Of Preparing A Jak1 Inhibitor
App 20210380563 - Zhou; Jiacheng ; et al. | 2021-12-09 |
Substituted Tricyclic Compounds As Fgfr Inhibitors
App 20210380587 - Wu; Liangxing ; et al. | 2021-12-09 |
Pyrazolopyridine Compounds And Uses Thereof
App 20210380581 - Vechorkin; Oleg ; et al. | 2021-12-09 |
Modulators of indoleamine 2,3-dioxygenase and methods of using the same
Grant 11,192,868 - Combs , et al. December 7, 2 | 2021-12-07 |
Pyrazolopyrimidine Compounds And Uses Thereof
App 20210371425 - Vechorkin; Oleg ; et al. | 2021-12-02 |
Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
Grant 11,186,580 - Douty , et al. November 30, 2 | 2021-11-30 |
Heterocyclic Compounds As Immunomodulators
App 20210363137 - Wu; Liangxing ; et al. | 2021-11-25 |
Fused Pyrimidine Compounds As Kras Inhibitors
App 20210355141 - Hoang; Gia ; et al. | 2021-11-18 |
Fused Tricyclic Kras Inhibitors
App 20210355121 - ZHU; Wenyu ; et al. | 2021-11-18 |
Bicyclic heterocycles as FGFR4 inhibitors
Grant 11,173,162 - Sokolsky , et al. November 16, 2 | 2021-11-16 |
Salts of an FGFR inhibitor
Grant 11,174,257 - Jia , et al. November 16, 2 | 2021-11-16 |
Heterocyclic Compounds As Immunomodulators
App 20210347771 - Wu; Liangxing ; et al. | 2021-11-11 |
Fused pyrimidine derivatives as A2A / A2B inhibitors
Grant 11,168,089 - Wang , et al. November 9, 2 | 2021-11-09 |
Tricyclic fused thiophene derivatives as JAK inhibitors
Grant 11,161,855 - Li , et al. November 2, 2 | 2021-11-02 |
Heterocyclic derivatives as PI3K inhibitors
Grant 11,161,838 - Shepard , et al. November 2, 2 | 2021-11-02 |
Fused pyrazine derivatives as A2A / A2B inhibitors
Grant 11,161,850 - Wang , et al. November 2, 2 | 2021-11-02 |
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders
App 20210332059 - Li; Yun-Long ; et al. | 2021-10-28 |
Tricyclic Heteroaryl Compounds As Sting Activators
App 20210332067 - Wu; Liangxing ; et al. | 2021-10-28 |
Cyclopropylamines as LSD1 inhibitors
Grant 11,155,532 - Wu , et al. October 26, 2 | 2021-10-26 |
Heterocyclic Compounds As Immunomodulators
App 20210317139 - Xiao; Kaijiong ; et al. | 2021-10-14 |
Pyrrolopyrimidine derivatives as TAM inhibitors
Grant 11,136,326 - Li , et al. October 5, 2 | 2021-10-05 |
Salts Of An Lsd1 Inhibitor And Processes For Preparing The Same
App 20210300891 - Jia; Zhongjiang ; et al. | 2021-09-30 |
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS
App 20210300925 - Combs; Andrew P. ; et al. | 2021-09-30 |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
Grant 11,130,767 - Li , et al. September 28, 2 | 2021-09-28 |
Heterocyclic compounds as immunomodulators
Grant 11,124,511 - Wu , et al. September 21, 2 | 2021-09-21 |
Combination Therapy Comprising Axl/mer And Pd-1/pd-l1 Inhibitors
App 20210275666 - Rios-Doria; Jonathan ; et al. | 2021-09-09 |
Pyrazolopyrimidine compounds and uses thereof
Grant 11,111,247 - Vechorkin , et al. September 7, 2 | 2021-09-07 |
Tricyclic Compounds As Inhibitors Of Kras
App 20210269434 - Wang; Xiaozhao ; et al. | 2021-09-02 |
JAK1 pathway inhibitors for the treatment of cytokine-related disorders
Grant 11,103,510 - Montgomery , et al. August 31, 2 | 2021-08-31 |
Salts of TAM inhibitors
Grant 11,104,682 - Jia , et al. August 31, 2 | 2021-08-31 |
Fused Pyrimidine Derivatives As A2a / A2b Inhibitors
App 20210261555 - Wang; Xiaozhao ; et al. | 2021-08-26 |
Processes for Preparing Jak Inhibitors and Related Intermediate Compounds
App 20210253584 - Zhou; Jiacheng ; et al. | 2021-08-19 |
Pyrimidinones As Pi3k Inhibitors
App 20210253601 - Li; Yun-Long ; et al. | 2021-08-19 |
Salts And Solid Forms And Processes Of Preparing A Pi3k Inhibitor
App 20210253582 - Chen; Shili ; et al. | 2021-08-19 |
Heterocyclic compounds as PI3K-y inhibitors
Grant 11,091,491 - Shvartsbart , et al. August 17, 2 | 2021-08-17 |
Tricyclic heterocycles as BET protein inhibitors
Grant 11,091,484 - Rodgers , et al. August 17, 2 | 2021-08-17 |
Crystalline solid forms of a BET inhibitor
Grant 11,091,480 - Chen , et al. August 17, 2 | 2021-08-17 |
Salts and processes of preparing a PI3K inhibitor
Grant 11,084,822 - Qiao , et al. August 10, 2 | 2021-08-10 |
Bipyrazole Derivatives As Jak Inhibitors
App 20210238168 - Li; Yun-Long ; et al. | 2021-08-05 |
Heterocyclic derivatives as PI3K inhibitors
Grant 11,078,204 - Shepard , et al. August 3, 2 | 2021-08-03 |
Spiro Compounds As Inhibitors Of Kras
App 20210230162 - Zhao; Le ; et al. | 2021-07-29 |
Anti-cd73 Antibodies And Uses Thereof
App 20210230293 - Nastri; Horacio G. ; et al. | 2021-07-29 |
Cd73 Inhibitor And A2a/a2b Adenosine Receptor Inhibitor Combination Therapy
App 20210230294 - Nastri; Horacio G. ; et al. | 2021-07-29 |
Heterocyclic Compounds As Immunomodulators
App 20210221819 - Li; Jingwei ; et al. | 2021-07-22 |
Salts of a Pim kinase inhibitor
Grant 11,066,387 - Jia , et al. July 20, 2 | 2021-07-20 |
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
Grant 11,066,404 - Sokolsky , et al. July 20, 2 | 2021-07-20 |
Solid forms of an HPK1 inhibitor
Grant 11,066,394 - Jia , et al. July 20, 2 | 2021-07-20 |
Bicyclic Heterocycles As Fgfr Inhibitors
App 20210214366 - Roach; Jeremy ; et al. | 2021-07-15 |
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
Grant 11,059,821 - Combs , et al. July 13, 2 | 2021-07-13 |
Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
App 20210205311 - Wang; Hui ; et al. | 2021-07-08 |
Heterocyclic compounds useful as Pim kinase inhibitors
Grant 11,053,215 - Vechorkin , et al. July 6, 2 | 2021-07-06 |
Substituted tricyclic compounds as FGFR inhibitors
Grant 11,053,246 - Wu , et al. July 6, 2 | 2021-07-06 |
Aminopyrazine derivatives as PI3K-.gamma. inhibitors
Grant 11,046,658 - Douty , et al. June 29, 2 | 2021-06-29 |
Sustained release dosage forms for a JAK1 inhibitor
Grant 11,045,421 - Yeleswaram , et al. June 29, 2 | 2021-06-29 |
Tricyclic Heterocycles As Bet Protein Inhibitors
App 20210188872 - Combs; Andrew P. ; et al. | 2021-06-24 |
Tricyclic Heterocycles As Fgfr Inhibitors
App 20210171535 - McCammant; Matthew S. ; et al. | 2021-06-10 |
Derivatives Of An Fgfr Inhibitor
App 20210171522 - Tao; Ming ; et al. | 2021-06-10 |
Benzothiazole Compounds And Uses Thereof
App 20210171518 - Hummel; Joshua ; et al. | 2021-06-10 |
Heteroaryl Amide Compounds As Sting Activators
App 20210163493 - Wu; Liangxing ; et al. | 2021-06-03 |
Combination Therapy Comprising An Alk2 Inhibitor And A Jak2 Inhibitor
App 20210154195 - CHEN; Yaoyu ; et al. | 2021-05-27 |
Salts Of A Pim Kinase Inhibitor
App 20210155605 - Jia; Zhongjiang ; et al. | 2021-05-27 |
Bicyclic heterocycles as FGFR4 inhibitors
Grant 11,014,923 - Lu , et al. May 25, 2 | 2021-05-25 |
Pyrazolopyrimidine compounds and uses thereof
Grant 11,014,929 - Vechorkin , et al. May 25, 2 | 2021-05-25 |
Pyrrolotriazine Compounds As Tam Inhibitors
App 20210147430 - Li; Yun-Long ; et al. | 2021-05-20 |
Tricyclic heteroaryl compounds as STING activators
Grant 11,008,344 - Wu , et al. May 18, 2 | 2021-05-18 |
Salts And Crystalline Forms Of A Pd-1/pd-l1 Inhibitor
App 20210139511 - Jia; Zhongjiang ; et al. | 2021-05-13 |
Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors
App 20210139485 - Wang; Xiaozhao ; et al. | 2021-05-13 |
Bipyrazole derivatives as JAK inhibitors
Grant 11,001,571 - Li , et al. May 11, 2 | 2021-05-11 |
Sustained-release Dosage Forms Of Ruxolitinib
App 20210128477 - Ni; Yong ; et al. | 2021-05-06 |
Salts Of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- Imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide And Processes Related To Preparing The Same
App 20210128568 - Weng; Lingkai ; et al. | 2021-05-06 |
Biomarkers For Graft-versus-host Disease
App 20210123930 - Howell; Michael D. ; et al. | 2021-04-29 |
Biomarkers For Graft-versus-host Disease
App 20210123931 - Howell; Michael D. ; et al. | 2021-04-29 |
Use Of Jak1 Inhibitors For The Treatment Of Cutaneous Lupus Erythematosus And Lichen Planus (lp)
App 20210113566 - Smith; Paul ; et al. | 2021-04-22 |
Bicyclic Heterocycles As Fgfr Inhibitors
App 20210115053 - Shvartsbart; Artem ; et al. | 2021-04-22 |
Heterocyclic Compounds As Immunomodulators
App 20210115068 - Wu; Liangxing ; et al. | 2021-04-22 |
Heterocyclic Compounds As Immunomodulators
App 20210115025 - Yu; Zhiyong ; et al. | 2021-04-22 |
Heterocyclic Compounds As Immunomodulators
App 20210107900 - Wu; Liangxing ; et al. | 2021-04-15 |
Bicyclic Heterocycles As Fgfr Inhibitors
App 20210106588 - Vechorkin; Oleg ; et al. | 2021-04-15 |
Crystalline Solid Forms Of A Bet Inhibitor
App 20210105998 - Chen; Shili ; et al. | 2021-04-15 |
Bicyclic Amines As Cdk2 Inhibitors
App 20210107901 - Ye; Yingda ; et al. | 2021-04-15 |
Process for preparing a composition comprising an enantiomeric excess of greater than or equal to 90% of the (R)-enantiomer of a compound of formula III
Grant 10,975,085 - Zhou , et al. April 13, 2 | 2021-04-13 |
Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
Grant 10,975,088 - Buesking , et al. April 13, 2 | 2021-04-13 |
Advanced gaming visualization system
Grant 10,974,134 - Arbouzov April 13, 2 | 2021-04-13 |
Salts of an LSD1 inhibitor and processes for preparing the same
Grant 10,968,200 - Jia , et al. April 6, 2 | 2021-04-06 |
Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors
Grant 10,968,221 - Wu , et al. April 6, 2 | 2021-04-06 |
Bicyclic Heterocycles As Fgfr Inhibitors
App 20210094935 - Vechorkin; Oleg ; et al. | 2021-04-01 |
Carboxamide Compounds And Uses Thereof
App 20210094934 - Vechorkin; Oleg ; et al. | 2021-04-01 |
Pyrido[3,2-d]pyrimidine Compounds As Immunomodulators
App 20210094976 - Li; Jingwei ; et al. | 2021-04-01 |
Treatment Of B-cell Malignancies By A Combination Jak And Pi3k Inhibitors
App 20210093638 - Scherle; Peggy A. ; et al. | 2021-04-01 |
Amorphous Solid Form Of A Bet Protein Inhibitor
App 20210079016 - Chen; Shili ; et al. | 2021-03-18 |
Tricyclic heterocyclic compounds as sting activators
Grant 10,947,227 - Wu , et al. March 16, 2 | 2021-03-16 |
Bicyclic heterocycles as FGFR inhibitors
Grant 10,947,230 - Sun , et al. March 16, 2 | 2021-03-16 |
Jak1 Inhibitors For The Treatment Of Myelodysplastic Syndromes
App 20210069193 - Vaddi; Krishna | 2021-03-11 |
Ruxolitinib Formulation For Reduction Of Itch In Atopic Dermatitis
App 20210069195 - Kuligowski; Michael ; et al. | 2021-03-11 |
Triazolopyrimidines As A2a / A2b Inhibitors
App 20210061809 - Han; Heeoon ; et al. | 2021-03-04 |
Pyrazolopyridine compounds and uses thereof
Grant 10,934,288 - Vechorkin , et al. March 2, 2 | 2021-03-02 |
Imidazolyl Pyrimidinylamine Compounds As Cdk2 Inhibitors
App 20210047294 - Ye; Qinda ; et al. | 2021-02-18 |
Tricyclic heterocycles as BET protein inhibitors
Grant 10,919,912 - Combs , et al. February 16, 2 | 2021-02-16 |
Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors
Grant 10,919,901 - Zhuo , et al. February 16, 2 | 2021-02-16 |
Solid Forms Of An Hpk1 Inhibitor
App 20210040071 - Jia; Zhongjiang ; et al. | 2021-02-11 |
Salts Of A Pd-1/pd-l1 Inhibitor
App 20210040090 - Jia; Zhongjiang ; et al. | 2021-02-11 |
Cyclopropylamines As Lsd1 Inhibitors
App 20210032244 - Wu; Liangxing ; et al. | 2021-02-04 |
Topical Treatment Of Vitiligo By A Jak Inhibitor
App 20210030672 - BUTLER; Kathleen ; et al. | 2021-02-04 |
Dosing Regimen For An Ido Inhibitor
App 20210030869 - Smith; Michael ; et al. | 2021-02-04 |
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase
App 20210030722 - Combs; Andrew P. ; et al. | 2021-02-04 |
Salts Of An Lsd1 Inhibitor
App 20210032203 - Pan; Yongchun ; et al. | 2021-02-04 |
Heterocyclic compounds as immunomodulators
Grant 10,906,920 - Wu , et al. February 2, 2 | 2021-02-02 |
Cyclopropylamines As Lsd1 Inhibitors
App 20210024487 - Wu; Liangxing ; et al. | 2021-01-28 |
Processes and intermediates for making a JAK inhibitor
Grant 10,899,736 - Wang , et al. January 26, 2 | 2021-01-26 |
Benzothiazole compounds and uses thereof
Grant 10,899,755 - Hummel , et al. January 26, 2 | 2021-01-26 |
Heterocyclic Compounds As Immunomodulators
App 20210017164 - Lu; Liang ; et al. | 2021-01-21 |
Heterocyclic Compounds As Immunomodulators
App 20210017175 - Li; Zhenwu ; et al. | 2021-01-21 |
Pyrazolyl Pyrimidinylamine Compounds As Cdk2 Inhibitors
App 20210017156 - Hummel; Joshua ; et al. | 2021-01-21 |
Bicyclic Heterocycles As Fgfr Inhibitors
App 20210009582 - Vechorkin; Oleg ; et al. | 2021-01-14 |
Heterocyclic Compounds As Immunomodulators
App 20210002276 - Wu; Liangxing ; et al. | 2021-01-07 |
Topical Formulation For A Jak Inhibitor
App 20210000832 - Parikh; Bhavnish ; et al. | 2021-01-07 |
Indazole Compounds And Uses Thereof
App 20210002288 - Sokolsky; Alexander ; et al. | 2021-01-07 |
Topical Treatment Of Vitiligo By A Jak Inhibitor
App 20200405627 - BUTLER; Kathleen ; et al. | 2020-12-31 |
Heterocyclic Compounds As Immunomodulators
App 20200407357 - Lajkiewicz; Neil ; et al. | 2020-12-31 |
Thiazolecarboxamides And Pyridinecarboxamide Compounds Useful As Pim Kinase Inhibitors
App 20200405702 - Xue; Chu-Biao ; et al. | 2020-12-31 |
Heteroaryl amide compounds as sting activators
Grant 10,875,872 - Wu , et al. December 29, 2 | 2020-12-29 |
Sustained-release dosage forms of ruxolitinib
Grant 10,874,616 - Ni , et al. December 29, 2 | 2020-12-29 |
Bicyclic Heterocycles As Fgfr4 Inhibitors
App 20200399267 - Lu; Liang ; et al. | 2020-12-24 |
Piperidin-4-yl Azetidine Derivatives As Jak1 Inhibitors
App 20200397774 - Huang; Taisheng ; et al. | 2020-12-24 |
Immunomodulator Compounds And Methods Of Use
App 20200397893 - Liu; Phillip C. ; et al. | 2020-12-24 |
Sulfonylamide Compounds As Cdk2 Inhibitors
App 20200399273 - Sokolsky; Alexander ; et al. | 2020-12-24 |
Topical formulation for a JAK inhibitor
Grant 10,869,870 - Parikh , et al. December 22, 2 | 2020-12-22 |
Pyrrolo[2,3-d]pyrimidinone Compounds As Cdk2 Inhibitors
App 20200392139 - Sokolsky; Alexander ; et al. | 2020-12-17 |
Heterocyclic Compounds As Lsd1 Inhibitors
App 20200392143 - He; Chunhong ; et al. | 2020-12-17 |
Topical Treatment Of Vitiligo By A Jak Inhibitor
App 20200383986 - BUTLER; Kathleen ; et al. | 2020-12-10 |
TERTIARY ALCOHOLS AS PI3K-y INHIBITORS
App 20200385392 - Douty; Brent ; et al. | 2020-12-10 |
Amorphous solid form of a BET protein inhibitor
Grant 10,858,372 - Chen , et al. December 8, 2 | 2020-12-08 |
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS
App 20200377502 - Combs; Andrew P. ; et al. | 2020-12-03 |
Substituted Tricyclic Compounds As Fgfr Inhibitors
App 20200377504 - Wu; Liangxing ; et al. | 2020-12-03 |
Bicyclic heterocycles as FGFR4 inhibitors
Grant 10,851,105 - Wu , et al. December 1, 2 | 2020-12-01 |
Topical Formulation For A Jak Inhibitor
App 20200368240 - PARIKH; Bhavnish ; et al. | 2020-11-26 |
Pyrrolotriazine compounds as TAM inhibitors
Grant 10,844,069 - Li , et al. November 24, 2 | 2020-11-24 |
Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
Grant 10,828,290 - Xue , et al. November 10, 2 | 2020-11-10 |
Pyrimidinones as PI3K inhibitors
Grant 10,829,502 - Li , et al. November 10, 2 | 2020-11-10 |
Tricyclic Amine Compounds As Cdk2 Inhibitors
App 20200347066 - Ye; Qinda ; et al. | 2020-11-05 |
Tricyclic Amine Compounds As Cdk2 Inhibitors
App 20200347067 - Ye; Qinda ; et al. | 2020-11-05 |
Salts Of Tam Inhibitors
App 20200347065 - Jia; Zhongjiang ; et al. | 2020-11-05 |
Biomarkers For Vitiligo
App 20200348313 - Howell; Michael D. ; et al. | 2020-11-05 |
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
App 20200338077 - Rodgers; James D. ; et al. | 2020-10-29 |
AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
App 20200339542 - Shepard; Stacey ; et al. | 2020-10-29 |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
Grant 10,813,930 - Yao , et al. October 27, 2 | 2020-10-27 |
3-(5-amino-pyrazin-2-yl)-benzenesulfonamide Derivatives And Related Compounds As Pi3k-gamma Kinase Inhibitors For Treating E.g. Cancer
App 20200331903 - SHVARTSBART; Artem ; et al. | 2020-10-22 |
Immunomodulator compounds and methods of use
Grant 10,806,785 - Lu , et al. October 20, 2 | 2020-10-20 |
Heterocyclic Compounds As Immunomodulators
App 20200325115 - Wu; Liangxing ; et al. | 2020-10-15 |
Heterocyclylamines As Pi3k Inhibitors
App 20200323858 - Li; Yun-Long ; et al. | 2020-10-15 |
Carboxamide compounds and uses thereof
Grant 10,800,761 - Vechorkin , et al. October 13, 2 | 2020-10-13 |
Heterocyclic compounds as LSD1 inhibitors
Grant 10,800,779 - He , et al. October 13, 2 | 2020-10-13 |
Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,- 4]triazin-2-yl]benzamide and processes related to preparing the same
Grant 10,799,509 - Weng , et al. October 13, 2 | 2020-10-13 |
Heterocyclic compounds as immunomodulators
Grant 10,800,768 - Wu , et al. October 13, 2 | 2020-10-13 |
Formulations Of An Lsd1 Inhibitor
App 20200316041 - Rocco; William L. ; et al. | 2020-10-08 |
Cyclin-dependent Kinase 2 Biomarkers And Uses Thereof
App 20200316064 - Ye; Min ; et al. | 2020-10-08 |
Imidazotriaines and Imidazopyrimidines as Kinase Inhibitors
App 20200317680 - Zhuo; Jincong ; et al. | 2020-10-08 |
Heterocyclic compounds as immunomodulators
Grant 10,793,565 - Wu , et al. October 6, 2 | 2020-10-06 |
Bicyclic Heterocycles As Fgfr4 Inhibitors
App 20200306256 - Lu; Liang ; et al. | 2020-10-01 |
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins
Grant 10,781,209 - Combs , et al. Sept | 2020-09-22 |
Methods Of Treating Cancer With An Fgfr Inhibitor
App 20200281907 - Ji; Tao ; et al. | 2020-09-10 |
Jak1 Pathway Inhibitors For The Treatment Of Chronic Lung Allograft Dysfunction
App 20200281931 - Schaub; Richard L. ; et al. | 2020-09-10 |
Heterocyclic Compounds As Immunomodulators
App 20200283423 - Yu; Zhiyong ; et al. | 2020-09-10 |
Pyrazolopyridine Compounds And Uses Thereof
App 20200283434 - Liu; Kai ; et al. | 2020-09-10 |
Crystalline Solid Forms Of A Bet Inhibitor
App 20200283436 - Chen; Shili ; et al. | 2020-09-10 |
Heterocyclic Compounds As Immunomodulators
App 20200277309 - Wu; Liangxing ; et al. | 2020-09-03 |
Topical formulation for a JAK inhibitor
Grant 10758543 - | 2020-09-01 |
Crystalline Forms Of A Fgfr Inhibitor And Processes For Preparing The Same
App 20200270245 - Pan; Yongchun ; et al. | 2020-08-27 |
Pyrazolopyridines And Triazolopyridines As A2a / A2b Inhibitors
App 20200270244 - Huang; Taisheng ; et al. | 2020-08-27 |
Indazole compounds and uses thereof
Grant 10752635 - | 2020-08-25 |
Indazole compounds and uses thereof
Grant 10745388 - | 2020-08-18 |
Sustained Release Dosage Forms For A Jak1 Inhibitor
App 20200253879 - Kind Code | 2020-08-13 |
Heterocyclic Compounds As Immunomodulators
App 20200255424 - Kind Code | 2020-08-13 |
Bicyclic heterocycles as FGFR4 inhibitors
Grant 10738048 - | 2020-08-11 |
Imidazotriaines and imidazopyrimidines as kinase inhibitors
Grant 10738052 - | 2020-08-11 |
Tertiary alcohols as PI3K-γ inhibitors
Grant 10738057 - | 2020-08-11 |
Bicyclic Heteroarylaminoalkyl Phenyl Derivatives As Pi3k Inhibitors
App 20200247820 - Kind Code | 2020-08-06 |
Imidazo[1,2-b][1,2,4]triazines As C-met Inhibitors
App 20200247811A1 - | 2020-08-06 |
Cyanoindazole compounds and uses thereof
Grant 10722495 - | 2020-07-28 |
Salts of an LSD1 inhibitor
Grant 10723700 - | 2020-07-28 |
Heterocyclic compounds and uses thereof
Grant 10723705 - | 2020-07-28 |
Cyclopropylamines as LSD1 inhibitors
Grant 10717737 - | 2020-07-21 |
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant 10695337 - | 2020-06-30 |
Jak1 Pathway Inhibitors For The Treatment Of Gastrointestinal Disease
App 20200197399 - Yeleswaram; Krishnaswamy ; et al. | 2020-06-25 |
Salts of the Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-YL)-1H-Pyrazol-1-YL)-3- Cyclopentylpropanenitrile
App 20200197401A1 - | 2020-06-25 |
Imidazopyridazine And Imidazopyridine Compounds And Uses Thereof
App 20200199131 - Pan; Jun ; et al. | 2020-06-25 |
Pharmaceutical Compositions And Methods For Indoleamine, 2, 3-dioxygenase Inhibition And Indications Therefor
App 20200179347 - Yeleswaram; Krishnaswamy ; et al. | 2020-06-11 |
Low Dose Combination Therapy For Treatment Of Myeloproliferative Neoplasms
App 20200179364A1 - | 2020-06-11 |
Cyclopropylamines As Lsd1 Inhibitors
App 20200181077 - Wu; Liangxing ; et al. | 2020-06-11 |
Heterocyclic Compounds As Immunomodulators
App 20200181126 - Lu; Liang ; et al. | 2020-06-11 |
Pyrrolopyrimidine Derivatives As Tam Inhibitors
App 20200181151 - Li; Yun-Long ; et al. | 2020-06-11 |
Cyclopropylamines as LSD1 inhibitors
Grant 10676457 - | 2020-06-09 |
Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors
Grant 10675284 - | 2020-06-09 |
Heterocyclic Compounds As Immunomodulators
App 20200172533 - Wu; Liangxing ; et al. | 2020-06-04 |
Heterocyclic Compounds As Immunomodulators
App 20200172541 - Li; Zhenwu ; et al. | 2020-06-04 |
Pyrazolopyrimidine Compounds And Uses Thereof
App 20200172545 - Vechorkin; Oleg ; et al. | 2020-06-04 |
Aminopyrazine diol compounds as PI3K-γ inhibitors
Grant 10669262 - | 2020-06-02 |
Heterocyclic compounds as immunomodulators
Grant 10669271 - | 2020-06-02 |
Thiazolecarboxamides And Pyridinecarboxamide Compounds Useful As Pim Kinase Inhibitors
App 20200155527A1 - | 2020-05-21 |
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant 10653677 - | 2020-05-19 |
Substituted Heterocyclic Derivatives As Pi3k Inhibitors
App 20200148667 - Shepard; Stacey ; et al. | 2020-05-14 |
Heterocyclic Derivatives As Pi3k Inhibitors
App 20200148671 - Shepard; Stacey ; et al. | 2020-05-14 |
Heterocyclic Derivatives As Pi3k Inhibitors
App 20200148689 - Shepard; Stacey ; et al. | 2020-05-14 |
Heterocyclylamines as PI3K inhibitors
Grant 10646492 - | 2020-05-12 |
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
Grant 10640503 - | 2020-05-05 |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
Grant 10639310 - | 2020-05-05 |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors
Grant 10640506 - | 2020-05-05 |
Combination Therapy For Treatment Of Hematological Diseases
App 20200129517 - Assad; Albert | 2020-04-30 |
Pyrrolotriazine Compounds As Tam Inhibitors
App 20200131185 - Li; Yun-Long ; et al. | 2020-04-30 |
Tricyclic Heterocycles As Bet Protein Inhibitors
App 20200131195A1 - | 2020-04-30 |
Bicyclic heterocycles as FGFR4 inhibitors
Grant 10632126 - | 2020-04-28 |
Salts of TAM inhibitors
Grant 10633387 - | 2020-04-28 |
Pyrimidinones As Pi3k Inhibitors
App 20200123176A1 - | 2020-04-23 |
Crystalline solid forms of a BET inhibitor
Grant 10626114 - | 2020-04-21 |
Dihydropyrido[2,3-d]pyrimidinone Compounds As Cdk2 Inhibitors
App 20200115378 - Sokolsky; Alexander ; et al. | 2020-04-16 |
Tricyclic heterocycles as BET protein inhibitors
Grant 10618910 - | 2020-04-14 |
Heterocyclic compounds as immunomodulators
Grant 10618916 - | 2020-04-14 |
Crystalline forms of a FGFR inhibitor and processes for preparing the same
Grant 10611762 - | 2020-04-07 |
Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
Grant 10610530 - | 2020-04-07 |
HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS
App 20200102315 - Buesking; Andrew W. ; et al. | 2020-04-02 |
Janus Kinase Inhibitors For Treatment Of Dry Eye And Other Eye Related Diseases
App 20200093825 - Friedman; Paul A. ; et al. | 2020-03-26 |
Bicyclic Heterocycles As Fgfr Inhibitors
App 20200095244 - Sun; Yaping ; et al. | 2020-03-26 |
Pyrazolopyrimidine Compounds And Uses Thereof
App 20200095250 - Vechorkin; Oleg ; et al. | 2020-03-26 |
Anti-pd-1 Antibodies And Uses Thereof
App 20200095322 - Cornfeld; Mark ; et al. | 2020-03-26 |
Low dose combination therapy for treatment of myeloproliferative neoplasms
Grant 10596161 - | 2020-03-24 |
Aza-heteroaryl compounds as PI3K-gamma inhibitors
Grant 10596184 - | 2020-03-24 |
Pyrazolopyridine Compounds And Uses Thereof
App 20200087301 - Vechorkin; Oleg ; et al. | 2020-03-19 |
Azetidinyl Phenyl, Pyridyl Or Pyrazinyl Carboxamide Derivatives As Jak Inhibitors
App 20200079783 - Yao; Wenqing ; et al. | 2020-03-12 |
Salts Of An Lsd1 Inhibitor And Processes For Preparing The Same
App 20200071289 - Jia; Zhongjiang ; et al. | 2020-03-05 |
Crystalline Forms Of A Phosphoinositide 3-kinase (pi3k) Inhibitor
App 20200071335 - Douty; Brent ; et al. | 2020-03-05 |
Biomarkers For Inflammatory Skin Disease
App 20200063188A1 - | 2020-02-27 |
Sustained release dosage forms for a JAK1 inhibitor
Grant 10561616 - | 2020-02-18 |
Benzothiazole Compounds And Uses Thereof
App 20200048241A1 - | 2020-02-13 |
Topical Formulation For A Jak Inhibitor
App 20200046707A1 - | 2020-02-13 |
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS
App 20200048251A1 - | 2020-02-13 |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
Grant 10556908 - | 2020-02-11 |
Tricyclic Heteraryl Compounds As Sting Activators
App 20200040009A1 - | 2020-02-06 |
Heteroaryl Amide Compounds As Sting Activators
App 20200039994A1 - | 2020-02-06 |
Tricyclic Fused Thiophene Derivatives As Jak Inhibitors
App 20200040002A1 - | 2020-02-06 |
METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
App 20200038404A1 - | 2020-02-06 |
| 